Roach's Introductory Clinical Pharmacology 11th Edition | PDF Guide & Drug Therapy Essentials

TESTBANKJFORJROACHESJINTRODUCTORYJCLINICALJP
HARMACOLOGYJ11THJEDITION


MULTIPLEJCHOICE
1. AJnursingJinstructorJisJpreparingJaJteachingJplanJforJaJgroupJofJnursingJstudentsJaboutJp
harmacology.JWhenJdescribingJthisJtopic,JtheJinstructorJwouldJfocusJtheJdiscussionJonJw
hichJofJtheJfollowingJasJanJessentialJaspect?
A) DrugJname
B) DrugJclass
C) DrugJaction
D) DrugJsource
JAns:J CJFeedbac

k:
PharmacologyJisJtheJstudyJofJdrugsJandJtheirJactionJonJlivingJorganisms.JThus,JanJessent
ialJaspectJofJpharmacologyJisJdrugJaction.JAnJunderstandingJofJtheJdrugJname,JdrugJclass
,JandJdrugJsourceJisJimportant,JbutJtheJmostJcriticalJaspectJrelatedJtoJpharmacologyJisJho
wJtheJdrugJactsJinJtheJbody.


2. AJnursingJstudentJisJpreparingJtoJadministerJaJprescribedJdrugJtoJaJpatient.JTheJstudentJre
viewsJinformationJaboutJtheJdrugJandJitsJactions.JWhichJofJtheJfollowingJwouldJbeJtheJbe
stJchoiceJforJobtainingJthisJinformation?JSelectJallJthatJapply.
A) NursingJinstructor
B) NurseJassignedJtoJtheJpatient
C) ClinicalJdrugJreference
D) PrescribingJhealthJcareJprovider
E) ClinicalJpharmacist
JAns:JC,JE
Feedback:
AlthoughJtheJnursingJstudentJcanJaskJtheJnursingJinstructor,JtheJnurseJassignedJtoJtheJpa
tient,JandJtheJprescribingJhealthJcareJproviderJforJinformationJaboutJtheJdrug,JtheJbestJch
oicesJforJdrugJinformationJwouldJincludeJanJappropriateJdrugJreferenceJandJtheJclinicalJ
pharmacist.


3. WhenJdescribingJtheJvariousJtypesJofJmedicationsJtoJaJgroupJofJnursingJstudents,JaJ
nursingJinstructorJwouldJidentifyJwhichJofJtheJfollowingJasJaJsourceJforJderivingJm
edications?JSelectJallJthatJapply.
A) Plants
B) SyntheticJsources
C) Mold
D) Minerals
E) AnimalsJAn
s:JA,JB,JC,JD,JE
Feedback:
MedicationsJareJderivedJfromJnaturalJsources,JforJexample,Jplants,Jmolds,Jminerals,JandJanim
als,JasJwellJasJcreatedJsyntheticallyJinJaJlaboratory.

MedConnoisseur

,4. WhichJofJtheJfollowingJnamesJmayJbeJassignedJtoJaJdrugJduringJtheJprocessJofJ
development?JSelectJallJthatJapply.
A) ChemicalJname
B) OfficialJname
C) PharmacologicJname
D) TradeJname
E) NonproprietaryJname
JAns:J A,JB,JD,JE
Feedback:
ThroughoutJtheJprocessJofJdevelopment,JdrugsJmayJhaveJseveralJnamesJassignedJtoJthe
mJincludingJaJchemicalJname,JaJgenericJ(nonproprietary)Jname,JanJofficialJname,JandJaJtr
adeJorJbrandJname.


5. AJdrugJmayJbeJclassifiedJ byJwhichJofJtheJfollowing?J SelectJallJthatJapply.
A) TheJchemicalJtypeJofJtheJdrug'sJactiveJingredient
B) TheJwayJtheJdrugJisJusedJtoJtreatJaJspecificJcondition
C) TheJgenericJnameJofJtheJdrug
D) TheJtradeJnameJofJtheJdrug
E) TheJnonproprietaryJnameJofJtheJdrugJ
Ans:JA,JB
Feedback:
AJdrugJmayJbeJclassifiedJbyJtheJchemicalJtypeJofJtheJactiveJingredientJorJbyJtheJwayJitJisJ
usedJtoJtreatJaJparticularJcondition.JGeneric,Jtrade,JandJnonproprietaryJreferJtoJhowJaJdru
gJisJnamed.


6. AJgroupJofJnursingJstudentsJareJreviewingJinformationJaboutJtheJprocessJofJdrugJdev
elopmentJinJtheJUnitedJStates.JTheJstudentsJdemonstrateJunderstandingJofJthisJproces
sJwhenJtheyJidentifyJthatJwhichJofJtheJfollowingJcategoriesJareJassignedJbyJtheJFoodJa
ndJDrugJAdministrationJtoJnewlyJapprovedJdrugs?JSelectJallJthatJapply.
A) Metabolite
B) NoncontrolledJsubstance
C) Prescription
D) Nonprescription
E) ControlledJsubstance
JAns:JC,JD,JE

Feedback:
OnceJdrugsJareJapprovedJforJuse,JtheJFDAJassignsJtheJdrugJtoJoneJofJtheJfollowingJcateg
ories:Jprescription,Jnonprescription,JorJcontrolledJsubstance.JMetaboliteJrefersJtoJtheJinac
tiveJformJofJtheJdrug.JNoncontrolledJsubstanceJisJaJtermJthatJisJnotJused.




PageJ 2

,7. WhichJofJtheJfollowingJwouldJbeJmostJimportantJforJtheJnurseJtoJdoJtoJensureJtheJsafeJ
useJofJprescriptionJdrugsJinJtheJinstitutionalJsetting?JSelectJallJthatJapply.
A) AdministeringJdrugs
B) MonitoringJclientsJforJdrugJeffects
C) PrescribingJdrugs
D) EvaluatingJclientsJforJtoxicJeffects
E) EducatingJclients/caregiversJaboutJdrugs
JAns:JA,JB,JD,JE
Feedback:
InJtheJinstitutionalJsetting,JtheJnurse'sJroleJtoJensureJsafeJuseJofJprescriptionJdrugsJinclud
esJadministeringJdrugs,JmonitoringJdrugJeffects,JevaluatingJforJtoxicJeffects,JandJeducati
ngJclientsJandJcaregiversJaboutJdrugs.


8. TheJnurseJisJhelpingJaJclientJreviewJaJprescriptionJfromJtheJhealthJcareJprovider.JWhenJ
examiningJtheJprescription,JwhichJofJtheJfollowingJwouldJtheJnurseJexpectJtoJfindJdocu
mented?JSelectJallJthatJapply.
A) NameJofJtheJdrug
B) DosageJofJtheJdrug
C) RouteJofJdrugJadministration
D) TimesJofJdrugJadministration
E) LicensedJprescriber'sJsignatureJ
Ans:JA,JB,JC,JD,JE
Feedback:
TheJprescriptionJmustJcontainJtheJclient'sJname,JtheJnameJofJtheJdrug,JtheJdosage,JtheJme
thodJandJtimesJofJadministration,JandJtheJsignatureJofJtheJlicensedJhealthJcareJproviderJp
rescribingJtheJdrug.


9. AfterJteachingJaJgroupJofJnursingJstudentsJaboutJnonprescriptionJdrugs,JtheJnursingJinst
ructorJdeterminesJthatJtheJteachingJwasJsuccessfulJwhenJtheJstudentsJidentifyJwhichJofJt
heJfollowing?JSelectJallJthatJapply.
A) TheyJrequireJaJlicensedJhealthJcareJprovider'sJsignature.
B) TheyJareJreferredJtoJasJover-the-counterJdrugs.
C) TheyJcanJbeJtakenJwithoutJriskJtoJtheJclient.
D) TheyJhaveJcertainJlabelingJrequirements.
E) TheyJshouldJbeJtakenJonlyJasJdirectedJonJtheJlabel.J
Ans:JB,JD,JE
Feedback:
NonprescriptionJdrugsJareJoftenJreferredJtoJasJover-the-
counterJ(OTC)Jdrugs.JTheyJdoJnotJrequireJaJprescriptionJ(aJlicensedJhealthJcareJprovider'
sJsignature)JbutJdoJnotJcomeJwithoutJriskJtoJtheJclient.JTheJfederalJgovernmentJhasJimpo
sedJlabelingJrequirementsJofJOTCJdrugsJandJtheyJshouldJonlyJbeJtakenJasJdirectedJonJthe
JlabelJunlessJunderJtheJsupervisionJofJaJhealthJcareJprovider.




PageJ 3

, 10. AJnursingJstudentJisJreviewingJinformationJaboutJtheJControlledJSubstancesJActJofJ1
970.JTheJstudentJwouldJexpectJtoJfindJwhichJofJtheJfollowingJasJbeingJregulatedJforJd
rugsJclassifiedJasJcontrolledJsubstances?JSelectJallJthatJapply.
A) Manufacturing
B) Elimination
C) Distribution
D) Formulation
E) Dispensing
JAns:JA,JC,JE
Feedback:
TheJControlledJSubstancesJActJofJ1970JregulatesJtheJmanufacture,Jdistribution,JandJdisp
ensingJofJdrugsJclassifiedJasJcontrolledJsubstances.JEliminationJrefersJtoJtheJexcretionJof
JdrugsJfromJtheJbody,JaJpharmacokineticJactivity.JTheJactJdoesJnotJaddressJformulationJo
fJtheJdrug.


11. WhenJreviewingJinformationJaboutJtheJOrphanJDrugJProgram,JwhichJofJtheJfollowingJ
wouldJtheJnurseJexpectJtoJfind?JSelectJallJthatJapply.
A) TheJprogramJencouragesJtheJdevelopmentJandJmarketingJofJproductsJtoJtreatJrareJ
diseases.
B) TheJprogramJgrantsJprovisionalJapprovalJwithJaJwrittenJcommitmentJfromJtheJ
drugJcompanyJtoJformallyJdemonstrateJclientJbenefits.
C) TheJprogramJprovidesJforJincentives,JsuchJasJresearchJgrants,JprotocolJassistance,J
andJspecialJtaxJcredits,JtoJdevelopJproductsJtoJtreatJrareJdiseases.
D) TheJprogramJgrantsJ7JyearsJofJexclusiveJmarketingJrightsJtoJtheJmanufacturerJifJ
approved.
E) TheJprogramJacceleratesJapprovalJofJdrugsJbasedJonJpreliminaryJevidenceJbeforeJ
formalJdemonstrationJofJclientJbenefits.
Ans:J A,JC,JD
Feedback:
TheJOrphanJDrugJProgramJencouragesJtheJdevelopmentJandJmarketingJofJproductsJusedJ
toJtreatJrareJdiseases.JTheJprogramJprovidesJincentivesJtoJencourageJmanufacturersJtoJde
velopJorphanJdrugs,JandJifJapproved,JtheJmanufacturerJhasJ7JyearsJofJexclusiveJmarketin
gJrights.JAcceleratedJprogramsJinvolveJprovisionalJapprovalJandJapprovalJbasedJonJpreli
minaryJevidence.




PageJ 4